<AdverseEventReport>
<!--
	BJ : Got this xml from demo (10-24-09), then 
   	- added reporting period
   	- remove contact mechanism in report and physician
   	- changed all empty elemnts to have explicit end tags
   	- Changed all Enums (eg: Grade, Hospitalization etc) to have their name instead of display name. 
-->
    <id>102</id>
    <createdAt xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">2009-10-01
        12:31:55.407
    </createdAt>
	<AdverseEventReportingPeriod>
		 <id>1</id>
		 <cycleNumber>1</cycleNumber>
	</AdverseEventReportingPeriod>
    <AdverseEventResponseDescription>
        <eventDescription>desc</eventDescription>
        <presentStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">DEAD
        </presentStatus>
        <recoveryDate>2009-10-01T00:00:00.000-04:00</recoveryDate>
        <retreated>false</retreated>
        <dateRemovedFromProtocol>2009-10-01T00:00:00.000-04:00</dateRemovedFromProtocol>
        <eventAbate xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">NA</eventAbate>
        <eventReappear xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">NA</eventReappear>
        <autopsyPerformed>false</autopsyPerformed>
        <primaryTreatmentApproximateTime>
            <type>0</type>
        </primaryTreatmentApproximateTime>
    </AdverseEventResponseDescription>
    <Physician>
        <firstName>pFirstName</firstName>
        <lastName>pLastName</lastName>
	</Physician>
    <Reporter>
        <firstName>Sameer</firstName>
        <lastName>Sawant</lastName>
        <address>
            <city>herndon</city>
            <state>va</state>
            <street>2100 wordsworth ct</street>
            <zip>20170</zip>
        </address>
    </Reporter>
    <DiseaseHistory>
        <diagnosisDate>
            <dayString>01</dayString>
            <monthString>10</monthString>
            <yearString>2009</yearString>
        </diagnosisDate>
        <CtepStudyDisease>
            <id>1</id>
            <leadDisease>true</leadDisease>
            <DiseaseTerm>
                <id>201</id>
                <term>Ovarian epithelial cancer</term>
                <ctepTerm>Ovarian epithelial cancer</ctepTerm>
                <DiseaseCategory>
                    <id>104</id>
                    <name>Ovarian Cancer (excluding Ovarian Germ Cell Cancer)</name>
                </DiseaseCategory>
            </DiseaseTerm>
        </CtepStudyDisease>
        <AnatomicSite>
            <id>8</id>
            <name>Skin</name>
            <category>Dermatology</category>
        </AnatomicSite>
        <MetastaticDiseaseSite>
            <id>41</id>
            <AnatomicSite>
                <id>8</id>
                <name>Skin</name>
                <category>Dermatology</category>
            </AnatomicSite>
        </MetastaticDiseaseSite>
    </DiseaseHistory>
    <ParticipantHistory>
        <height>
            <quantity>414</quantity>
            <unit>Centimeter</unit>
        </height>
        <weight>
            <quantity>43</quantity>
            <unit>Kilogram</unit>
        </weight>
        <baselinePerformanceStatus>0 = Normal Activity, asymptomatic</baselinePerformanceStatus>
        <bsa>2.8049</bsa>
    </ParticipantHistory>
    <StudyParticipantAssignment>
        <dateOfEnrollment>2009-10-01T10:50:17.000-04:00</dateOfEnrollment>
        <StudySite>
            <statusCode>false</statusCode>
            <Study>
                <id>1</id>
                <multiInstitutionIndicator>true</multiInstitutionIndicator>
                <shortTitle>A Phase II Trial of Gemcitabine in Combination with 17-Allylaminogeldanamycin (17-AAG) in
                    Advanced Epithelial Ovarian and Primary Peritoneal Carcinoma
                </shortTitle>
                <longTitle>A Phase II Trial of Gemcitabine in Combination with 17-Allylaminogeldanamycin (17-AAG) in
                    Advanced Epithelial Ovarian and Primary Peritoneal Carcinoma
                </longTitle>
                <description>A Phase II Trial of Gemcitabine in Combination with 17-Allylaminogeldanamycin (17-AAG) in
                    Advanced Epithelial Ovarian and Primary Peritoneal Carcinoma
                </description>
                <phaseCode>Phase II Trial</phaseCode>
                <status>Active - Trial is open to accrual</status>
                <Ctc>
                    <id>3</id>
                    <name>CTCAE v3.0</name>
                </Ctc>
                <Identifier>
                    <type>Protocol Authority Identifier</type>
                    <value>6307</value>
                    <primaryIndicator>true</primaryIndicator>
                </Identifier>
                <Identifier>
                    <type>Coordinating Center Identifier</type>
                    <value>MC0362</value>
                    <primaryIndicator>false</primaryIndicator>
                </Identifier>
                <StudyAgent>
                    <Agent>
                        <id>21</id>
                        <name>17-AAG</name>
                        <nscNumber>330507</nscNumber>
                    </Agent>
                    <INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">
                        CTEP_IND
                    </INDType>
                </StudyAgent>
                <StudyAgent>
                    <Agent>
                        <id>483</id>
                        <name>Gemcitabine hydrochloride</name>
                        <nscNumber>613327</nscNumber>
                    </Agent>
                    <INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">
                        NA_COMMERCIAL
                    </INDType>
                </StudyAgent>
                <StudyAgent>
                    <Agent>
                        <id>386</id>
                        <name>EPL Diluent</name>
                        <nscNumber>704057</nscNumber>
                    </Agent>
                    <INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">
                        OTHER
                    </INDType>
                </StudyAgent>
                <CtepStudyDisease>
                    <id>1</id>
                    <leadDisease>true</leadDisease>
                    <DiseaseTerm>
                        <id>201</id>
                        <term>Ovarian epithelial cancer</term>
                        <ctepTerm>Ovarian epithelial cancer</ctepTerm>
                        <DiseaseCategory>
                            <id>104</id>
                            <name>Ovarian Cancer (excluding Ovarian Germ Cell Cancer)</name>
                        </DiseaseCategory>
                    </DiseaseTerm>
                </CtepStudyDisease>
                <CtepStudyDisease>
                    <id>2</id>
                    <leadDisease>false</leadDisease>
                    <DiseaseTerm>
                        <id>204</id>
                        <term>Primary peritoneal carcinoma</term>
                        <ctepTerm>Primary peritoneal carcinoma</ctepTerm>
                        <DiseaseCategory>
                            <id>104</id>
                            <name>Ovarian Cancer (excluding Ovarian Germ Cell Cancer)</name>
                        </DiseaseCategory>
                    </DiseaseTerm>
                </CtepStudyDisease>
                <CtepStudyDisease>
                    <id>3</id>
                    <leadDisease>false</leadDisease>
                    <DiseaseTerm>
                        <id>98</id>
                        <term>Hematopoietic malignancy, NOS</term>
                        <ctepTerm>Hematopoietic malignancy, NOS</ctepTerm>
                        <DiseaseCategory>
                            <id>59</id>
                            <name>Hematopoietic Neoplasm, Miscellaneous</name>
                        </DiseaseCategory>
                    </DiseaseTerm>
                </CtepStudyDisease>
                <CtepStudyDisease>
                    <id>4</id>
                    <leadDisease>false</leadDisease>
                    <DiseaseTerm>
                        <id>190</id>
                        <term>Solid tumor, NOS</term>
                        <ctepTerm>Solid tumor, NOS</ctepTerm>
                        <DiseaseCategory>
                            <id>95</id>
                            <name>Solid Tumor, Miscellaneous</name>
                        </DiseaseCategory>
                    </DiseaseTerm>
                </CtepStudyDisease>
            </Study>
            <Organization>
                <id>104522</id>
                <name>Mayo Clinic Rochester</name>
                <nciInstituteCode>MN026</nciInstituteCode>
                <SiteInvestigator>
                    <id>1</id>
                    <Investigator>
                        <id>100000</id>
                        <firstName>Robert</firstName>
                        <lastName>McWilliams</lastName>
                        <nciIdentifier>36894</nciIdentifier>
                        <emailAddress>site.physician@gmail.com</emailAddress>
                        <phoneNumber>5072842511</phoneNumber>
                        <faxNumber>5072845280</faxNumber>
                    </Investigator>
                </SiteInvestigator>
            </Organization>
        </StudySite>
        <Participant>
            <firstName>Madhuri</firstName>
            <lastName>Dixit</lastName>
            <dateOfBirth>
                <dayString>09</dayString>
                <monthString>09</monthString>
                <yearString>1970</yearString>
            </dateOfBirth>
            <gender>Female</gender>
            <race>Asian</race>
            <ethnicity>Hispanic or Latino</ethnicity>
            <Identifier>
                <type>Other</type>
                <value>dixitm</value>
                <primaryIndicator>true</primaryIndicator>
            </Identifier>
            <Identifier>
                <type>CC</type>
                <value>dixitMayo</value>
                <primaryIndicator>false</primaryIndicator>
            </Identifier>
        </Participant>
        <studySubjectIdentifier>dixit6307</studySubjectIdentifier>
    </StudyParticipantAssignment>
    <ConcomitantMedication>
        <name>conco meditcation</name>
        <startDate>
            <dayString>01</dayString>
            <monthString>10</monthString>
            <yearString>2009</yearString>
        </startDate>
        <endDate></endDate>
        <stillTakingMedications>true</stillTakingMedications>
    </ConcomitantMedication>
    <AdverseEvent>
        <gridId>PRY2ca2230a-7085-4094-83d7-2ce6b1738464</gridId>
        <startDate>2009-10-01T00:00:00.000-04:00</startDate>
        <expected>true</expected>
        <ConcomitantMedicationAttribution>
            <id>182</id>
            <attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">POSSIBLE</attribution>
            <ConcomitantMedication>
                <name>conco meditcation</name>
                <startDate>
                    <dayString>01</dayString>
                    <monthString>10</monthString>
                    <yearString>2009</yearString>
                </startDate>
                <endDate></endDate>
                <stillTakingMedications>true</stillTakingMedications>
            </ConcomitantMedication>
        </ConcomitantMedicationAttribution>
        <CourseAgentAttribution>
            <id>181</id>
            <attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">POSSIBLE</attribution>
            <CourseAgent>
                <id>122</id>
                <lastAdministeredDate>2009-10-01T00:00:00.000-04:00</lastAdministeredDate>
                <Dose>
                    <amount>323</amount>
                    <units>mEq</units>
                </Dose>
                <StudyAgent>
                    <Agent>
                        <id>21</id>
                        <name>17-AAG</name>
                        <nscNumber>330507</nscNumber>
                    </Agent>
                    <INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">
                        CTEP_IND
                    </INDType>
                </StudyAgent>
            </CourseAgent>
        </CourseAgentAttribution>
        <DiseaseAttribution>
            <id>183</id>
            <attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">POSSIBLE</attribution>
            <DiseaseHistory>
                <id>102</id>
                <diagnosisDate>
                    <dayString>01</dayString>
                    <monthString>10</monthString>
                    <yearString>2009</yearString>
                </diagnosisDate>
                <CtepStudyDisease>
                    <id>1</id>
                    <leadDisease>true</leadDisease>
                    <DiseaseTerm>
                        <id>201</id>
                        <term>Ovarian epithelial cancer</term>
                        <ctepTerm>Ovarian epithelial cancer</ctepTerm>
                        <DiseaseCategory>
                            <id>104</id>
                            <name>Ovarian Cancer (excluding Ovarian Germ Cell Cancer)</name>
                        </DiseaseCategory>
                    </DiseaseTerm>
                </CtepStudyDisease>
                <AnatomicSite>
                    <id>8</id>
                    <name>Skin</name>
                    <category>Dermatology</category>
                </AnatomicSite>
                <MetastaticDiseaseSite>
                    <id>41</id>
                    <AnatomicSite>
                        <id>8</id>
                        <name>Skin</name>
                        <category>Dermatology</category>
                    </AnatomicSite>
                </MetastaticDiseaseSite>
            </DiseaseHistory>
        </DiseaseAttribution>
        <AdverseEventCtcTerm other-required="false" med-dRA="false">
            <ctc-term>
                <id>3123</id>
                <term>Adrenal insufficiency</term>
                <ctepTerm>Adrenal insufficiency</ctepTerm>
                <ctepCode>10001367</ctepCode>
                <otherRequired>false</otherRequired>
                <CtcCategory>
                    <id>310</id>
                    <name>ENDOCRINE</name>
                </CtcCategory>
            </ctc-term>
            <universal-term>Adrenal insufficiency</universal-term>
            <term xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="CtcTerm">
                <id>3123</id>
                <term>Adrenal insufficiency</term>
                <ctepTerm>Adrenal insufficiency</ctepTerm>
                <ctepCode>10001367</ctepCode>
                <otherRequired>false</otherRequired>
                <CtcCategory>
                    <id>310</id>
                    <name>ENDOCRINE</name>
                </CtcCategory>
            </term>
            <full-name>Adrenal insufficiency</full-name>
        </AdverseEventCtcTerm>
        <attributionSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">POSSIBLE</attributionSummary>
        <grade xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">DEATH</grade>
        <hospitalization xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">YES</hospitalization>
        <eventApproximateTime>
            <type>0</type>
        </eventApproximateTime>
        <Outcome>
            <id>142</id>
            <OutcomeType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">DEATH
            </OutcomeType>
        </Outcome>
        <Outcome>
            <id>143</id>
            <OutcomeType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">
                HOSPITALIZATION
            </OutcomeType>
        </Outcome>
    </AdverseEvent>
    <AdverseEvent>
        <gridId>PRN40dcddd8-6b47-475e-871c-4906dd94b379</gridId>
        <startDate>2009-10-01T00:00:00.000-04:00</startDate>
        <expected>true</expected>
        <ConcomitantMedicationAttribution>
            <id>185</id>
            <attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">POSSIBLE</attribution>
            <ConcomitantMedication>
                <name>conco meditcation</name>
                <startDate>
                    <dayString>01</dayString>
                    <monthString>10</monthString>
                    <yearString>2009</yearString>
                </startDate>
 				<endDate></endDate>
                <stillTakingMedications>true</stillTakingMedications>
            </ConcomitantMedication>
        </ConcomitantMedicationAttribution>
        <CourseAgentAttribution>
            <id>184</id>
            <attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">POSSIBLE</attribution>
            <CourseAgent>
                <id>122</id>
                <lastAdministeredDate>2009-10-01T00:00:00.000-04:00</lastAdministeredDate>
                <Dose>
                    <amount>323</amount>
                    <units>mEq</units>
                </Dose>
                <StudyAgent>
                    <Agent>
                        <id>21</id>
                        <name>17-AAG</name>
                        <nscNumber>330507</nscNumber>
                    </Agent>
                    <INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">
                        CTEP_IND
                    </INDType>
                </StudyAgent>
            </CourseAgent>
        </CourseAgentAttribution>
        <DiseaseAttribution>
            <id>186</id>
            <attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">POSSIBLE</attribution>
            <DiseaseHistory>
                <id>102</id>
                <diagnosisDate>
                    <dayString>01</dayString>
                    <monthString>10</monthString>
                    <yearString>2009</yearString>
                </diagnosisDate>
                <CtepStudyDisease>
                    <id>1</id>
                    <leadDisease>true</leadDisease>
                    <DiseaseTerm>
                        <id>201</id>
                        <term>Ovarian epithelial cancer</term>
                        <ctepTerm>Ovarian epithelial cancer</ctepTerm>
                        <DiseaseCategory>
                            <id>104</id>
                            <name>Ovarian Cancer (excluding Ovarian Germ Cell Cancer)</name>
                        </DiseaseCategory>
                    </DiseaseTerm>
                </CtepStudyDisease>
                <AnatomicSite>
                    <id>8</id>
                    <name>Skin</name>
                    <category>Dermatology</category>
                </AnatomicSite>
                <MetastaticDiseaseSite>
                    <id>41</id>
                    <AnatomicSite>
                        <id>8</id>
                        <name>Skin</name>
                        <category>Dermatology</category>
                    </AnatomicSite>
                </MetastaticDiseaseSite>
            </DiseaseHistory>
        </DiseaseAttribution>
        <AdverseEventCtcTerm other-required="false" med-dRA="false">
            <ctc-term>
                <id>3589</id>
                <term>ALT, SGPT (serum glutamic pyruvic transaminase)</term>
                <ctepTerm>Alanine aminotransferase increased</ctepTerm>
                <ctepCode>10001551</ctepCode>
                <otherRequired>false</otherRequired>
                <CtcCategory>
                    <id>317</id>
                    <name>METABOLIC/LABORATORY</name>
                </CtcCategory>
            </ctc-term>
            <universal-term>ALT, SGPT (serum glutamic pyruvic transaminase)</universal-term>
            <term xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="CtcTerm">
                <id>3589</id>
                <term>ALT, SGPT (serum glutamic pyruvic transaminase)</term>
                <ctepTerm>Alanine aminotransferase increased</ctepTerm>
                <ctepCode>10001551</ctepCode>
                <otherRequired>false</otherRequired>
                <CtcCategory>
                    <id>317</id>
                    <name>METABOLIC/LABORATORY</name>
                </CtcCategory>
            </term>
            <full-name>ALT, SGPT (serum glutamic pyruvic transaminase)</full-name>
        </AdverseEventCtcTerm>
        <attributionSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">POSSIBLE</attributionSummary>
        <grade xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">DEATH</grade>
        <hospitalization xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">YES</hospitalization>
        <eventApproximateTime>
            <type>0</type>
        </eventApproximateTime>
        <Outcome>
            <id>141</id>
            <OutcomeType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">
                HOSPITALIZATION
            </OutcomeType>
        </Outcome>
    </AdverseEvent>
    <AdverseEvent>
        <gridId>PRN984a4a4e-bccd-4300-9319-bd719036c87f</gridId>
        <startDate>2009-10-01T00:00:00.000-04:00</startDate>
        <expected>true</expected>
        <ConcomitantMedicationAttribution>
            <id>188</id>
            <attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">POSSIBLE</attribution>
            <ConcomitantMedication>
                <name>conco meditcation</name>
                <startDate>
                    <dayString>01</dayString>
                    <monthString>10</monthString>
                    <yearString>2009</yearString>
                </startDate>
                 <endDate></endDate>
                <stillTakingMedications>true</stillTakingMedications>
            </ConcomitantMedication>
        </ConcomitantMedicationAttribution>
        <CourseAgentAttribution>
            <id>187</id>
            <attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">POSSIBLE</attribution>
            <CourseAgent>
                <id>122</id>
                <lastAdministeredDate>2009-10-01T00:00:00.000-04:00</lastAdministeredDate>
                <Dose>
                    <amount>323</amount>
                    <units>mEq</units>
                </Dose>
                <StudyAgent>
                    <Agent>
                        <id>21</id>
                        <name>17-AAG</name>
                        <nscNumber>330507</nscNumber>
                    </Agent>
                    <INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">
                        CTEP_IND
                    </INDType>
                </StudyAgent>
            </CourseAgent>
        </CourseAgentAttribution>
        <DiseaseAttribution>
            <id>189</id>
            <attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">POSSIBLE</attribution>
            <DiseaseHistory>
                <id>102</id>
                <diagnosisDate>
                    <dayString>01</dayString>
                    <monthString>10</monthString>
                    <yearString>2009</yearString>
                </diagnosisDate>
                <CtepStudyDisease>
                    <id>1</id>
                    <leadDisease>true</leadDisease>
                    <DiseaseTerm>
                        <id>201</id>
                        <term>Ovarian epithelial cancer</term>
                        <ctepTerm>Ovarian epithelial cancer</ctepTerm>
                        <DiseaseCategory>
                            <id>104</id>
                            <name>Ovarian Cancer (excluding Ovarian Germ Cell Cancer)</name>
                        </DiseaseCategory>
                    </DiseaseTerm>
                </CtepStudyDisease>
                <AnatomicSite>
                    <id>8</id>
                    <name>Skin</name>
                    <category>Dermatology</category>
                </AnatomicSite>
                <MetastaticDiseaseSite>
                    <id>41</id>
                    <AnatomicSite>
                        <id>8</id>
                        <name>Skin</name>
                        <category>Dermatology</category>
                    </AnatomicSite>
                </MetastaticDiseaseSite>
            </DiseaseHistory>
        </DiseaseAttribution>
        <AdverseEventCtcTerm other-required="false" med-dRA="false">
            <ctc-term>
                <id>3124</id>
                <term>Cushingoid appearance (e.g., moon face, buffalo hump, centripetal obesity, cutaneous striae)
                </term>
                <ctepTerm>Cushingoid</ctepTerm>
                <ctepCode>10011655</ctepCode>
                <otherRequired>false</otherRequired>
                <CtcCategory>
                    <id>310</id>
                    <name>ENDOCRINE</name>
                </CtcCategory>
            </ctc-term>
            <universal-term>Cushingoid appearance (e.g., moon face, buffalo hump, centripetal obesity, cutaneous striae)
            </universal-term>
            <term xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="CtcTerm">
                <id>3124</id>
                <term>Cushingoid appearance (e.g., moon face, buffalo hump, centripetal obesity, cutaneous striae)
                </term>
                <ctepTerm>Cushingoid</ctepTerm>
                <ctepCode>10011655</ctepCode>
                <otherRequired>false</otherRequired>
                <CtcCategory>
                    <id>310</id>
                    <name>ENDOCRINE</name>
                </CtcCategory>
            </term>
            <full-name>Cushingoid appearance (e.g., moon face, buffalo hump, centripetal obesity, cutaneous striae)
            </full-name>
        </AdverseEventCtcTerm>
        <attributionSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">POSSIBLE</attributionSummary>
        <grade xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">MODERATE</grade>
        <hospitalization xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">YES</hospitalization>
        <eventApproximateTime>
            <type>0</type>
        </eventApproximateTime>
        <Outcome>
            <id>144</id>
            <OutcomeType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">
                HOSPITALIZATION
            </OutcomeType>
        </Outcome>
    </AdverseEvent>
    <SAEReportPriorTherapy>
        <id>101</id>
        <PriorTherapy>
            <id>1</id>
            <text>Anti-retroviral Therapy</text>
            <meddraTerm>90003000</meddraTerm>
        </PriorTherapy>
        <startDate>
            <dayString>01</dayString>
            <monthString>10</monthString>
            <yearString>2009</yearString>
        </startDate>
        <endDate>
            <dayString>02</dayString>
            <monthString>10</monthString>
            <yearString>2009</yearString>
        </endDate>
    </SAEReportPriorTherapy>
    <Summary id="Study">
        <value>(6307) A Phase II Trial of Gemcitabine in Combination with 17-Allylaminogeldanamycin (17-AAG) in Advanced
            Epithelial Ovarian and Primary Peritoneal Carcinoma
        </value>
    </Summary>
    <Summary id="Participant">
        <value>(dixitm) Madhuri Dixit</value>
    </Summary>
    <Summary id="Report created at">
        <value>2009-10-01 12:31:55.407</value>
    </Summary>
    <Summary id="Primary AE">
        <value>Adrenal insufficiency</value>
    </Summary>
    <Summary id="AE count">
        <value>3</value>
    </Summary>
    <Summary id="Public identifier">
        <value>MN026-MN026</value>
    </Summary>
    <Summary id="Ticket number"></Summary>
    <Summary id="Next report due"></Summary>
    <Summary id="Course">
        <value></value>
    </Summary>
    <TreatmentInformation>
        <firstCourseDate>2009-10-01T00:00:00.000-04:00</firstCourseDate>
        <treatmentDescription>Other Treatment Assignment from course.</treatmentDescription>
        <totalCourses>1</totalCourses>
        <investigationalAgentAdministered>true</investigationalAgentAdministered>
        <AdverseEventCourse>
            <number>1</number>
            <date>2009-10-01T00:00:00.000-04:00</date>
        </AdverseEventCourse>
        <CourseAgent>
            <id>122</id>
            <lastAdministeredDate>2009-10-01T00:00:00.000-04:00</lastAdministeredDate>
            <Dose>
                <amount>323</amount>
                <units>mEq</units>
            </Dose>
            <StudyAgent>
                <Agent>
                    <id>21</id>
                    <name>17-AAG</name>
                    <nscNumber>330507</nscNumber>
                </Agent>
                <INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">CTEP_IND
                </INDType>
            </StudyAgent>
        </CourseAgent>
    </TreatmentInformation>
    <SAEReportPreExistingCondition>
        <id>61</id>
        <PreExistingCondition>
            <id>1</id>
            <text>Anemia</text>
        </PreExistingCondition>
    </SAEReportPreExistingCondition>
    <AdditionalInformation>
        <id>102</id>
        <autopsyReport>false</autopsyReport>
        <consults>false</consults>
        <dischargeSummary>false</dischargeSummary>
        <flowCharts>false</flowCharts>
        <labReports>false</labReports>
        <obaForm>false</obaForm>
        <other>false</other>
        <pathologyReport>false</pathologyReport>
        <progressNotes>false</progressNotes>
        <radiologyReports>false</radiologyReports>
        <referralLetters>false</referralLetters>
        <irbReport>false</irbReport>
    </AdditionalInformation>
    <Report>
        <id>262</id>
        <adeersReportTypeIndicator>Regular report</adeersReportTypeIndicator>
        <ReportDefinition>
            <id>2</id>
            <duration>10</duration>
            <timeScaleUnitType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">
                DAY
            </timeScaleUnitType>
        </ReportDefinition>
        <ReportVersion>
            <reportVersionId>0</reportVersionId>
        </ReportVersion>
        <emailRecipient>sameer.sawant@semanticbits.com</emailRecipient>
    </Report>
</AdverseEventReport>